Product NDC: | 47335-956 |
Proprietary Name: | Alfuzosin Hydrochloride |
Non Proprietary Name: | Alfuzosin Hydrochloride |
Active Ingredient(s): | 10 mg/1 & nbsp; Alfuzosin Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 47335-956 |
Labeler Name: | Sun Pharma Global FZE |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA079057 |
Marketing Category: | ANDA |
Start Marketing Date: | 20111122 |
Package NDC: | 47335-956-18 |
Package Description: | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-956-18) |
NDC Code | 47335-956-18 |
Proprietary Name | Alfuzosin Hydrochloride |
Package Description | 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (47335-956-18) |
Product NDC | 47335-956 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Alfuzosin Hydrochloride |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20111122 |
Marketing Category Name | ANDA |
Labeler Name | Sun Pharma Global FZE |
Substance Name | ALFUZOSIN HYDROCHLORIDE |
Strength Number | 10 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |